Actinogen Medical makes bold A$11.1m move to boost Alzheimer’s drug trial

Pallavi Madhiraju- September 18, 2024 0

Actinogen Medical has raised 11.1 million AUD in a significant capital raise led by its CEO, Dr. Steven Gourlay, who personally invested 1 million AUD. ... Read More

Fresenius sells IV manufacturing site in Chile to Medifarma as part of streamlining efforts

Pallavi Madhiraju- September 2, 2024 0

Fresenius SE & Co. KGaA, a global healthcare company headquartered in Germany, announced the divestment of its intravenous (IV) manufacturing site in Chile, Laboratorio Sanderson ... Read More

Sun Pharma introduces STARIZO to tackle drug-resistant skin infections in India

Pallavi Madhiraju- August 24, 2024 0

Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting Acute Bacterial Skin and Skin Structure Infections ... Read More

Zydus Lifesciences to acquire 50% stake in Sterling Biotech from Perfect Day to expand into sustainable protein market

Pallavi Madhiraju- August 24, 2024 0

Zydus Lifesciences Limited, a major player in the global pharmaceutical industry, has entered a pivotal partnership by acquiring a 50% stake in Sterling Biotech Limited ... Read More

Big pharma shakeup: Lupin sells women’s health arm for mega millions

Pallavi Madhiraju- July 15, 2024 0

Lupin Limited, a global pharmaceutical leader, has officially divested its U.S. Commercial Women’s Health Specialty Business to Evofem Biosciences, Inc., a company specializing in women's ... Read More

Tentative approval granted to Alembic Pharmaceuticals for pulmonary hypertension treatment by FDA

Pallavi Madhiraju- July 13, 2024 0

Alembic Pharmaceuticals Limited has achieved a significant milestone by securing tentative approval from the US Food & Drug Administration (USFDA) for its Selexipag for Injection, ... Read More

Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets

Pallavi Madhiraju- July 4, 2024 0

Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil ... Read More

Kirloskar Pneumatic to acquire majority stake in Systems & Components India

Pallavi Madhiraju- June 21, 2024 0

Kirloskar Pneumatic Company Ltd. (BSE: 505283, NSE: KIRLPNU), a prominent entity in the air, refrigeration, and gas compressor sectors, has signed a memorandum of understanding ... Read More

Lupin Limited appoints Abdelaziz Toumi as CEO of new subsidiary

Pallavi Madhiraju- June 18, 2024 0

Global pharmaceutical giant, Lupin Limited, announced the appointment of Abdelaziz Toumi (commonly known as Abdel) as the Chief Executive Officer of its newly established subsidiary, ... Read More

Lupin Limited expands global specialty portfolio with strategic acquisitions

Pallavi Madhiraju- June 6, 2024 0

Global pharmaceutical leader Lupin Limited (Lupin) has announced the completion of a strategic acquisition through its European hub, Lupin Atlantis Holdings SA. The company has ... Read More